NCT02751424 A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830 Status TERMINATED Phase PHASE1
NCT02751294 A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution Status COMPLETED Phase PHASE1
NCT02750943 Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease Status COMPLETED Phase NA
NCT02750930 Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects Status TERMINATED Phase PHASE4
NCT02750189 The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea Status COMPLETED Phase N/A
NCT02742766 Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects Status COMPLETED Phase PHASE1
NCT02742753 Impact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish Children Status COMPLETED Phase N/A
NCT02741557 Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV) Status COMPLETED Phase PHASE1
NCT02738931 Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations Status COMPLETED Phase PHASE1
NCT02737007 A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607 Status COMPLETED Phase PHASE1
NCT02735915 Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older Status COMPLETED Phase PHASE3
NCT02731846 A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status WITHDRAWN Phase PHASE3
NCT02731833 Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity Status COMPLETED Phase PHASE4
NCT02730364 An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu Status WITHDRAWN Phase PHASE3
NCT02730351 Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB) Status COMPLETED Phase PHASE4
NCT02729051 Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT02729038 Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function Status COMPLETED Phase PHASE1
NCT02727283 A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02723955 Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) Status COMPLETED Phase PHASE1